<DOC>
	<DOCNO>NCT01420120</DOCNO>
	<brief_summary>This prospective multicenter registry evaluate safety performance REMEDY , biodegradable peripheral stent treatment occlude stenotic superficial femoral artery . Patients follow period 1 year .</brief_summary>
	<brief_title>Remedy , Biodegradable Peripheral Stent Registry</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Patients symptomatic leg ischemia require treatment SFA artery proximal popliteal artery locate within follow parameter : 1 cm femoral bifurcation SFA 3 cm proximal margin intercondylar fossa RutherfordBecker Category 25 . In patient bilateral lesion , high Rutherford Category limb treat . Only 1 leg include . Single lesion cover one stent . Target vessel reference diameter ≥ 4 mm ≤ 6 mm ( visual estimate ) A patent popliteal artery free significant stenosis ( &gt; 50 % ) least one patent vessel runoff confirm baseline angiography Signed informed consent . Pregnancy Previous stenting target lesion Acute ischemia Untreated inflow disease ipsilateral pelvic artery ( 50 % stenosis occlusion ) . Inclusion patient allow case inflow lesion successfully treated indexprocedure yield less 30 % diameter stenosis . Significant gastrointestinal bleeding coagulopathy would contraindicate use antiplatelet therapy Known intolerance study medication contrast agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Biodegradable stent , PAD</keyword>
</DOC>